Prostate Cancer
Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer.
January 18, 2023
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: a retrospective bicenter study by the SFRO Brachytherapy Group.
January 18, 2023
Developing a novel patient reported outcomes measure for prostate cancer patients receiving radionuclide therapy.
January 18, 2023
Defining Patient Benefits from High-intensity Intermittent Therapy for Hormone-sensitive Prostate Cancer.
January 17, 2023
A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer.
January 17, 2023
Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer: The Impact of Primary versus Secondary PatternĀ 5.
January 16, 2023
Prostate cancer disparities among American Indians/Alaskan Natives in the United States.
January 13, 2023